 |
|
|
|
|
|
Name: |
|
Keith L. Black MD |
|
|
|
|
Title: |
|
Director |
|
|
|
|
|
|
Facility: |
|
Cedars-Sinai Maxine Dunitz Neurosurgical Institute |
|
|
|
|
|
|
Location: |
|
8631 W. Third Street
Suite 800 E
Los Angeles, CA USA |
|
|
|
|
Phone: |
|
310-423-7900 |
|
|
|
|
|
|
Fax: |
|
(310) 423-0810 |
|
|
|
|
Email: |
|
Click here to send an email |
|
|
|
|
|
|
Website: |
|
www.cedars-sinai.edu/mdnsi |
|
|
|
|
|
|
|
Name: |
|
Maria Castro PhD |
|
|
|
|
Title: |
|
Professor and Co-Director |
|
|
|
|
|
|
Facility: |
|
Cedars-Sinai Maxine Dunitz Neurosurgical Institute |
|
|
|
|
|
|
Location: |
|
Gene Therapeutics Research Institute and Dept. Med
8700 Beverly Boulevard, Research Pavilion, Rm 5090
Los Angeles, CA USA |
|
|
|
|
Phone: |
|
310-423-7303 |
|
|
|
|
|
|
Fax: |
|
310-423-7308 |
|
|
|
|
Email: |
|
Click here to send an email |
|
|
|
|
|
|
Website: |
|
www.cshs.org/gtri |
|
|
|
|
|
|
|
Name: |
|
Adam Mamelak MD |
|
|
|
|
Title: |
|
|
|
|
|
|
|
|
Facility: |
|
Cedars-Sinai Maxine Dunitz Neurosurgical Institute |
|
|
|
|
|
|
Location: |
|
Contact: Elina Mindlin, RN,BS
Los Angeles, CA USA |
|
|
|
|
Phone: |
|
310-423-7900 |
|
|
|
|
|
|
Fax: |
|
|
|
|
|
|
Email: |
|
Click here to send an email |
|
|
|
|
|
|
Website: |
|
|
|
|
|
|
|
|
|
Name: |
|
John Yu MD |
|
|
|
|
Title: |
|
Assistant Clinical Professor, UCI |
|
|
|
|
|
|
Facility: |
|
Cedars-Sinai Maxine Dunitz Neurosurgical Institute |
|
|
|
|
|
|
Location: |
|
8631 West Third St.
Suite 800E
Los Angeles, CA USA |
|
|
|
|
Phone: |
|
310-423-7900 |
|
|
|
|
|
|
Fax: |
|
(310)423-0810 |
|
|
|
|
Email: |
|
Click here to send an email |
|
|
|
|
|
|
Website: |
|
www.cedars-sinai.edu/mdnsi |
|
|
There are 11 listings:
|
|
|
|
|
|
Treatment
|
|
Location |
|
Last Updated |
|
|
|
Details |
|
A Study of ICT-107(Vaccine therapy) in Glioblastoma Multiforme (GBM) |
|
Los Angeles, CA |
|
09/24/2012 |
|
|
|
|
|
Details |
|
Bevacizumab (Avastin) and Erlotinib (Tarceva) After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
Los Angeles, CA |
|
11/12/2010 |
|
|
|
Details |
|
Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma |
|
Los Angeles, CA |
|
01/24/2010 |
|
|
|
|
|
Details |
|
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
|
Los Angeles, CA |
|
08/11/2009 |
|
|
|
Details |
|
A Phase l Trial of Tumor Associated Antigen Pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
|
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
Details |
|
Phase II Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients with Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Phase I Study Of Pioglitazone And Isotretinoin In Patients With Recurrent Or Progressive Malignant Gliomas |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
Details |
|
Pilot Study of Bevacizamab in Patients with Recurrent or Progressive Primary Brain Tumors |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Phase I study of Gefitinib plus Rapamycin for patients with recurrent malignant glioma. |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
Details |
|
Improving Quality Of Life For Brain Tumor Patients |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
|
|
